Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 106 AL 120

An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects

Sharma P, Singh M.

Life Sci. 2023 May 1;320:121568. doi: 10.1016/j.lfs.2023.121568. Epub 2023 Mar 15.

Newer modalities in the management of Alzheimer's dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases

Marsool MDM, Prajjwal P, Reddy YB, Marsool ADM, Lam JR, Nandwana V.

Dis Mon. 2023 May;69(5):101547. doi: 10.1016/j.disamonth.2023.101547. Epub 2023 Mar 15.

Antioxidants: an approach for restricting oxidative stress induced neurodegeneration in Alzheimer's disease

Dubey S, Singh E.

Inflammopharmacology. 2023 Apr;31(2):717-730. doi: 10.1007/s10787-023-01173-5. Epub 2023 Mar 18.

The effectiveness and safety of Jihwang-eumja (Dihuang Yizi) compared to Western medications in patients with Alzheimer's disease: A systematic review and meta-analysis

Kim JY, Lee JY, Jung JH, Park YC, Jung IC.

Complement Ther Clin Pract. 2023 May;51:101746. doi: 10.1016/j.ctcp.2023.101746. Epub 2023 Mar 14.

The potential roles of ATF family in the treatment of Alzheimer's disease

Yang T, Zhang Y, Chen L, Thomas ER, Yu W, Cheng B, Li X.

Biomed Pharmacother. 2023 May;161:114544. doi: 10.1016/j.biopha.2023.114544. Epub 2023 Mar 17.

Nanomedicine-driven therapeutic interventions of autophagy and stem cells in the management of Alzheimer's disease

Alhodieb FS, Rahman MA, Barkat MA, Alanezi AA, Barkat HA, Hadi HA, Harwansh RK, Mittal V.

Nanomedicine (Lond). 2023 Jan;18(2):145-168. doi: 10.2217/nnm-2022-0108. Epub 2023 Mar 20.

AGEs RAGE Pathways: Alzheimer's Disease

Maheshwari S.

Drug Res (Stuttg). 2023 Jun;73(5):251-254. doi: 10.1055/a-2008-7948. Epub 2023 Mar 20.

Investigating Partially Discordant Results in Phase 3 Studies of Aducanumab

Mallinckrodt C, Tian Y, Aisen PS, Barkhof F, Cohen S, Dent G, Hansson O, Harrison K, Iwatsubo T, Mummery CJ, Muralidharan KK, Nestorov I, Nisenbaum L, Rajagovindan R, von Hehn C, van Dyck CH, Vellas B, Wu S, Zhu Y, Sandrock A, Chen T, Budd Haeberlein S.

J Prev Alzheimers Dis. 2023;10(2):171-177. doi: 10.14283/jpad.2023.6.

Beyond "Psychotropic": Repurposing Psychiatric Drugs for COVID-19, Alzheimer's Disease, and Cancer

Lenze EJ, Reiersen AM, Zorumski CF, Santosh PJ.

J Clin Psychiatry. 2023 Mar 20;84(3):22r14494. doi: 10.4088/JCP.22r14494.

The endoplasmic reticulum stress and unfolded protein response in Alzheimer's disease: A calcium dyshomeostasis perspective

Lim D, Tapella L, Dematteis G, Genazzani AA, Corazzari M, Verkhratsky A.

Ageing Res Rev. 2023 Jun;87:101914. doi: 10.1016/j.arr.2023.101914. Epub 2023 Mar 21.

Improper Application of a Rivastigmine Patch to the Back of the Neck Induced Toxic Symptoms

Matsuzono K, Mita Y, Imai G, Fujimoto S.

Intern Med. 2023 Nov 1;62(21):3247-3250. doi: 10.2169/internalmedicine.1236-22. Epub 2023 Mar 22.

Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review

Jalili C, Kiani A, Gholami M, Bahrehmand F, Fakhri S, Kakehbaraei S, Kakebaraei S.

IET Nanobiotechnol. 2023 May;17(3):154-170. doi: 10.1049/nbt2.12127. Epub 2023 Mar 22.

APOE and immunity: Research highlights

Kloske CM, Barnum CJ, Batista AF, Bradshaw EM, Brickman AM, Bu G, Dennison J, Gearon MD, Goate AM, Haass C, Heneka MT, Hu WT, Huggins LKL, Jones NS, Koldamova R, Lemere CA, Liddelow SA, Marcora E, Marsh SE, Nielsen HM, Petersen KK, Petersen M, Piña-Escudero SD, Qiu WQ, Quiroz YT, Reiman E, Sexton C, Tansey MG, Tcw J, Teunissen CE, Tijms BM, van der Kant R, Wallings R, Weninger SC, Wharton W, Wilcock DM, Wishard TJ, Worley SL, Zetterberg H, Carrillo MC.

Alzheimers Dement. 2023 Jun;19(6):2677-2696. doi: 10.1002/alz.13020. Epub 2023 Mar 28.

The Role of the Transcription Factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities

De Plano LM, Calabrese G, Rizzo MG, Oddo S, Caccamo A.

Biomolecules. 2023 Mar 17;13(3):549. doi: 10.3390/biom13030549.

From the gut to the blood-brain barrier: Novel approaches for the treatment and targeted delivery of therapeutics in Alzheimer's disease

Nicolazzo JA, Abasszade JH.

Adv Drug Deliv Rev. 2023 May;196:114818. doi: 10.1016/j.addr.2023.114818. Epub 2023 Mar 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias